These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 16205695)
21. The predicted effect of changes in cervical screening practice in the UK: results from a modelling study. Canfell K; Barnabas R; Patnick J; Beral V Br J Cancer; 2004 Aug; 91(3):530-6. PubMed ID: 15266332 [TBL] [Abstract][Full Text] [Related]
22. What is the most cost-effective population-based cancer screening program for Chinese women? Woo PP; Kim JJ; Leung GM J Clin Oncol; 2007 Feb; 25(6):617-24. PubMed ID: 17308266 [TBL] [Abstract][Full Text] [Related]
23. The projected timeframe until cervical cancer elimination in Australia: a modelling study. Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of a hospital based cytology screening programme for reduction in life time risk of cervical cancer. Agarwal SS; Murthy NS; Sharma S; Sharma KC; Das DK Neoplasma; 1995; 42(2):93-6. PubMed ID: 7617084 [TBL] [Abstract][Full Text] [Related]
25. Epidemiologic and Health Economic Evaluation of Cervical Cancer Screening in Rural China. Zhao F; Wen Y; Li Y; Tao S; Ma L; Zhao Y; Dang L; Wang Y; Zhao F; Lang J; Qiao Y; Yang CX Asian Pac J Cancer Prev; 2020 May; 21(5):1317-1325. PubMed ID: 32458639 [TBL] [Abstract][Full Text] [Related]
26. Silent killer of the night: a feasibility study of an outreach well-women clinic for cervical cancer screening in female sex workers in Hong Kong. Wong WC; Wun YT; Chan KW; Liu Y Int J Gynecol Cancer; 2008; 18(1):110-5. PubMed ID: 17466035 [TBL] [Abstract][Full Text] [Related]
27. The potential impact of a prophylactic vaccine for human papillomavirus on the current cervical screening programme in Hong Kong. Koljonen PA Hong Kong Med J; 2007 Aug; 13(4):304-10. PubMed ID: 17664535 [TBL] [Abstract][Full Text] [Related]
28. Cervical cancer in Croatia: state of the art and possibilities for prevention. Znaor A; Strnad M Coll Antropol; 2007 Apr; 31 Suppl 2():37-40. PubMed ID: 17598503 [TBL] [Abstract][Full Text] [Related]
29. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141 [TBL] [Abstract][Full Text] [Related]
30. Projections of cervical cancer mortality and incidence in New Zealand: the possible impact of screening. Cox B; Skegg DC J Epidemiol Community Health; 1992 Aug; 46(4):373-7. PubMed ID: 1431710 [TBL] [Abstract][Full Text] [Related]
31. How many cervical cancer cases can potentially be prevented using a more sensitive screening test at young age? de Kok IM; van Rosmalen J; Rozemeijer K; Penning C; van Ballegooijen M Int J Cancer; 2014 Jan; 134(2):460-6. PubMed ID: 23824905 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of abnormal Papanicolaou smears in female sex workers in Hong Kong. Leung KM; Yeoh GP; Cheung HN; Fong FY; Chan KW Hong Kong Med J; 2013 Jun; 19(3):203-6. PubMed ID: 23650200 [TBL] [Abstract][Full Text] [Related]
33. Description of the national situation of cervical cancer screening in the member states of the European Union. Anttila A; Ronco G; Eur J Cancer; 2009 Oct; 45(15):2685-708. PubMed ID: 19744852 [TBL] [Abstract][Full Text] [Related]
34. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative pap smears. van Oortmarssen GJ; Habbema JD Int J Epidemiol; 1995 Apr; 24(2):300-7. PubMed ID: 7635589 [TBL] [Abstract][Full Text] [Related]
35. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands. van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129 [TBL] [Abstract][Full Text] [Related]
36. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Falcaro M; Castañon A; Ndlela B; Checchi M; Soldan K; Lopez-Bernal J; Elliss-Brookes L; Sasieni P Lancet; 2021 Dec; 398(10316):2084-2092. PubMed ID: 34741816 [TBL] [Abstract][Full Text] [Related]
37. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme. Nygård JF; Sauer T; Nygård M; Skare GB; Thoresen SØ J Med Screen; 2004; 11(2):70-6. PubMed ID: 15153321 [TBL] [Abstract][Full Text] [Related]
38. Organised screening for cervical cancer in France: a cost-effectiveness assessment. Barré S; Massetti M; Leleu H; De Bels F BMJ Open; 2017 Oct; 7(10):e014626. PubMed ID: 28988162 [TBL] [Abstract][Full Text] [Related]
39. Increasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006. Foley G; Alston R; Geraci M; Brabin L; Kitchener H; Birch J Br J Cancer; 2011 Jun; 105(1):177-84. PubMed ID: 21654675 [TBL] [Abstract][Full Text] [Related]
40. Screening for cervical intraepithelial neoplasia in north east Scotland shows fall in incidence and mortality from invasive cancer with concomitant rise in preinvasive disease. Macgregor JE; Campbell MK; Mann EM; Swanson KY BMJ; 1994 May; 308(6941):1407-11. PubMed ID: 8019250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]